Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Norgine Pharmaceuticals Limited, Norgine House, Widewater place, Moorhall Road, Harefield, Middlesex, UB9 6NS, UK
Isoket Retard 20 Tablets.
| Pharmaceutical Form |
|---|
|
Prolonged release tablets. White with break score, marked IR 20 on the upper side and with SCHWARZ PHARMA on the reverse side. |
Each tablet contains isosorbide dinitrate 20 mg in a prolonged release formulation.
Excipients with known effect: 157.95 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Isosorbide dinitrate |
Isosorbide dinitrate is an organic nitrate, which in common with other cardioactive nitrates, is a vasodilator. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Cartons of blister strips of polypropylene (PP) and aluminium or of PP/PP.
Pack sizes 50, 56, 60, 84 and 90 tablets.
Only the pack sizes marked in bold are currently marketed.
Norgine Pharmaceuticals Limited, Norgine House, Widewater place, Moorhall Road, Harefield, Middlesex, UB9 6NS, UK
PL 20011/0048
Date of first authorisation: 01 June 1981
Date of latest renewal: 30 June 2008
| Drug | Countries | |
|---|---|---|
| ISOKET | Germany, Estonia, Ireland, Lithuania, Malta, Mexico, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
